Dr. Zhang Peng
Qualification: PhD from Shanghai University of TCM Orthopedics & Traumatology.
Clinical studies including Yaotongkang (3rd phase) (New traditional Chinese drug of class III) .
01/2004-10/2 Research work supported by the National Natural Science Foundation of China (Code: 3047222). As a major researcher in Ruijin Hospital (One of China’s largest hospital)
